JP2017514522A5 - - Google Patents

Download PDF

Info

Publication number
JP2017514522A5
JP2017514522A5 JP2017510445A JP2017510445A JP2017514522A5 JP 2017514522 A5 JP2017514522 A5 JP 2017514522A5 JP 2017510445 A JP2017510445 A JP 2017510445A JP 2017510445 A JP2017510445 A JP 2017510445A JP 2017514522 A5 JP2017514522 A5 JP 2017514522A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
modified human
human amino
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017510445A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017514522A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/028645 external-priority patent/WO2015168469A1/en
Publication of JP2017514522A publication Critical patent/JP2017514522A/ja
Publication of JP2017514522A5 publication Critical patent/JP2017514522A5/ja
Pending legal-status Critical Current

Links

JP2017510445A 2014-05-02 2015-04-30 ヒト化可変性リンパ球受容体(vlr)および組成物ならびにそれに関連する使用 Pending JP2017514522A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461987566P 2014-05-02 2014-05-02
US61/987,566 2014-05-02
PCT/US2015/028645 WO2015168469A1 (en) 2014-05-02 2015-04-30 Humanized variable lymphocyte receptors (vlr) and compositions and uses related thereto

Publications (2)

Publication Number Publication Date
JP2017514522A JP2017514522A (ja) 2017-06-08
JP2017514522A5 true JP2017514522A5 (cg-RX-API-DMAC7.html) 2018-06-14

Family

ID=54359347

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017510445A Pending JP2017514522A (ja) 2014-05-02 2015-04-30 ヒト化可変性リンパ球受容体(vlr)および組成物ならびにそれに関連する使用

Country Status (8)

Country Link
US (3) US10167330B2 (cg-RX-API-DMAC7.html)
EP (1) EP3137496A4 (cg-RX-API-DMAC7.html)
JP (1) JP2017514522A (cg-RX-API-DMAC7.html)
KR (1) KR20160147787A (cg-RX-API-DMAC7.html)
CN (1) CN106459173A (cg-RX-API-DMAC7.html)
CA (1) CA2947429A1 (cg-RX-API-DMAC7.html)
IL (1) IL248327A0 (cg-RX-API-DMAC7.html)
WO (1) WO2015168469A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2947429A1 (en) 2014-05-02 2015-11-05 Emory University Humanized variable lymphocyte receptors (vlr) and compositions and uses related thereto
SE1500434A1 (en) * 2015-10-29 2017-04-30 Theravac Pharmaceuticals Ab A novel fusion partner for highly efficient and safe vaccines
CN107365387B (zh) 2016-05-12 2022-03-15 阿思科力(苏州)生物科技有限公司 一种双特异性抗原结合构建体及其制备方法和应用
US11339225B2 (en) * 2016-05-12 2022-05-24 Asclepius (Suzhou) Technology Company Group, Co., Ltd. Bispecific antigen-binding construct and preparation method and use thereof
CN106543278B (zh) * 2016-12-06 2019-04-12 阿思科力(苏州)生物科技有限公司 融合蛋白Slit2D2(C386S)-HSA及其在治疗纤维化疾病中的应用
US20200138966A1 (en) * 2017-01-27 2020-05-07 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Bifunctional small peptide for autoimmune diabetes
US20200048321A1 (en) * 2017-03-24 2020-02-13 Orpheus Bioscience Inc. Pantids for treatment of autoimmune disorders
BR112019020940A2 (pt) * 2017-04-11 2020-05-05 Inhibrx, Inc. construções polipeptídicas multipecíficas que têm ligação a cd3 restrita e métodos de usar as mesmas
KR101972894B1 (ko) * 2017-05-18 2019-04-29 경상대학교산학협력단 소수성 테일 도메인이 제거된 먹장어 유래 vlrb 단백질에 칠성장어 유래 vlrb 단백질의 c 말단 서열이 연결된 융합 단백질 및 이의 용도
IL323061A (en) 2018-04-11 2025-10-01 Inhibrx Biosciences Inc Multispecific polypeptide constructs with forced CD3 binding and related methods and uses
WO2020023553A1 (en) 2018-07-24 2020-01-30 Inhibrx, Inc. Multispecific polypeptide constructs containing a constrained cd3 binding domain and a receptor binding region and methods of using the same
CN113166263A (zh) 2018-10-11 2021-07-23 印希比股份有限公司 Dll3单域抗体及其治疗性组合物
WO2020132301A1 (en) * 2018-12-21 2020-06-25 Wisconsin Alumni Research Foundation Variable lymphocyte receptors that target the brain extracellular matrix and methods of use
US12371468B2 (en) 2019-02-11 2025-07-29 Wisconsin Alumni Research Foundation Variable lymphocyte receptors that target the blood brain barrier and methods of use
WO2023010060A2 (en) 2021-07-27 2023-02-02 Novab, Inc. Engineered vlrb antibodies with immune effector functions
CN114891799B (zh) * 2022-05-20 2024-10-11 宁波大学 中华绒螯蟹可变淋巴受体vlr2基因及其编码的蛋白和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1118777A (ja) * 1997-07-09 1999-01-26 Asahi Chem Ind Co Ltd 新規スリット様ポリペプチド
CA2564251C (en) * 2004-05-21 2018-04-10 The Uab Research Foundation Variable lymphocyte receptors, related polypeptides and nucleic acids, and uses thereof
CA2659574C (en) 2006-08-02 2017-04-25 The Uab Research Foundation Methods and compositions related to soluble monoclonal variable lymphocyte receptors of defined antigen specificity
WO2010065407A2 (en) 2008-12-01 2010-06-10 University Of Maryland Biotechnology Institute High affinity recombinant sea lamprey antibodies selected by a yeast surface display platform
PH12013501201A1 (en) 2010-12-09 2013-07-29 Univ Pennsylvania Use of chimeric antigen receptor-modified t cells to treat cancer
CN104066751A (zh) 2011-11-22 2014-09-24 马里兰州大学(巴尔的摩) 对聚糖具有高亲和力和选择性的lambody及其用途
CN103033617B (zh) * 2012-11-30 2014-12-03 辽宁师范大学 基于可变淋巴细胞受体的肿瘤标志物检测试剂盒及其制备方法
UY35468A (es) 2013-03-16 2014-10-31 Novartis Ag Tratamiento de cáncer utilizando un receptor quimérico de antígeno anti-cd19
CA2947429A1 (en) 2014-05-02 2015-11-05 Emory University Humanized variable lymphocyte receptors (vlr) and compositions and uses related thereto

Similar Documents

Publication Publication Date Title
JP2017514522A5 (cg-RX-API-DMAC7.html)
JP2015212284A5 (cg-RX-API-DMAC7.html)
JP7094103B2 (ja) インフルエンザウイルスワクチンおよびその使用
JP2015096070A5 (cg-RX-API-DMAC7.html)
JP2017538401A5 (cg-RX-API-DMAC7.html)
RU2017134456A (ru) Рекомбинантные связывающие белки и их применение
MX2018010824A (es) Proteinas de union inducibles y metodos de uso.
JP2014510519A5 (cg-RX-API-DMAC7.html)
HRP20251060T1 (hr) Samosklapajuće proteinske nanostrukture koje prikazuju f proteine paramiksovirusa i/ili pneumovirusa i njihova uporaba
JP2016527891A5 (cg-RX-API-DMAC7.html)
JP2021505201A5 (cg-RX-API-DMAC7.html)
JP2018528253A5 (cg-RX-API-DMAC7.html)
IL288541B (en) Vaccine against rsv
JP2018528237A5 (cg-RX-API-DMAC7.html)
JP2018531624A5 (cg-RX-API-DMAC7.html)
JP2015524422A5 (cg-RX-API-DMAC7.html)
JP2008524261A5 (cg-RX-API-DMAC7.html)
JP2015509707A5 (cg-RX-API-DMAC7.html)
JP2015529678A5 (cg-RX-API-DMAC7.html)
JP2017524380A5 (ja) 腫瘍血管遮断剤であるポリペプチド、遺伝子、発現ベクター、腫瘍血管遮断剤の組成物、及び腫瘍血管遮断剤であるポリペプチドの調製方法
JP2015514811A5 (cg-RX-API-DMAC7.html)
JP2016501266A5 (cg-RX-API-DMAC7.html)
HK1215441A1 (zh) 人血清白蛋白结合化合物及其融合蛋白
JP2017529870A5 (cg-RX-API-DMAC7.html)
JP2016508503A5 (cg-RX-API-DMAC7.html)